XNAS · RXST
-2.26% · -$0.1200 · Vol 1.1M
Market closed · last close 4:00 PM ET · price as of 16:19:26 ET
RxSight, Inc. Common Stock

RxSight, Inc. Common Stock

OPHTHALMIC GOODS
$5.20
Card
Relationship Map

Follow $RXST

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $RXST by email

Veridion Score

BETALOW CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
RXST
RxSight, Inc. Common Stock
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is RXST moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading RXST catalysts
About RxSight, Inc. Common Stock
OPHTHALMIC GOODS
Listed since
2021
Employees
461
Country
US

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.25
Day high
$5.36
Day low
$5.17
Previous close
$5.32
52W high
$13.09
-60.28% from high
52W low
$4.59
7% of range
Market cap
$221.3M
EPS
$-1.2000
Beta
0.15
Shares out
41.6M
Volume
1.1M
1.29× rel vol
Avg volume
830.9K
VWAP
$5.24
Price history computed in-house
1W
-13.62%
1M
-14.61%
3M
+9.94%
1Y
-44.74%
YTD
-50.10%
SMA 50 $6.09 · below
SMA 200 $7.35 · below
52W position 7%

RXST overview

Veridion Score
59
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around RXST.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading RXST Form 4 filings
Public disclosures

Congress activity in RXST

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for RXST in the cached public ledger.

Federal contracts

RXST contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RXST in this window.
Lobbying spend

RXST lobbying filings, year to date.

Registered lobbying filings matched to RxSight, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RXST in this window.
Loading news for RXST
Analyst ratings
Sovereign unlock shows live analyst consensus for RXST.
Options
Sovereign unlock shows live options positioning for RXST.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.